Wolfgang Koenig Selected Research

Coronary Disease (Coronary Heart Disease)

1/2021	Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
12/2020	Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study.
1/2020	Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
1/2020	In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events.
1/2020	Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.
12/2019	Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
1/2019	Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
1/2019	Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study.
1/2018	Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial.
1/2018	Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang Koenig Research Topics

Disease

107	Inflammation (Inflammations) 10/2022 - 07/2002
95	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2002
68	Coronary Disease (Coronary Heart Disease) 01/2021 - 07/2002
64	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2003
60	Myocardial Infarction 10/2022 - 07/2002
43	Atherosclerosis 10/2022 - 04/2002
40	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 07/2002
29	Stroke (Strokes) 12/2021 - 02/2005
24	Hypertension (High Blood Pressure) 01/2022 - 08/2005
22	Insulin Resistance 01/2022 - 10/2006
22	Atherosclerotic Plaque (Atheroma) 12/2021 - 01/2007
21	Acute Coronary Syndrome 01/2022 - 04/2003
18	Obesity 01/2022 - 07/2003
17	Heart Failure 01/2022 - 02/2009
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 11/2003
12	Prediabetic State (Prediabetes) 01/2021 - 07/2011
10	Chronic Renal Insufficiency 01/2022 - 02/2007
10	Dyslipidemias (Dyslipidemia) 12/2020 - 11/2009
9	Thrombosis (Thrombus) 01/2020 - 03/2009
9	Diabetes Mellitus 01/2020 - 01/2003
9	Glucose Intolerance 01/2019 - 12/2005
8	Unstable Angina 10/2018 - 07/2002
8	Neoplasms (Cancer) 10/2017 - 02/2008
7	Chest Pain (Chest Pains) 11/2017 - 03/2009
6	Polyneuropathies (Polyneuropathy) 01/2022 - 01/2015
6	Overweight 11/2021 - 01/2007
5	Abdominal Obesity 01/2022 - 07/2008
5	Kidney Diseases (Kidney Disease) 06/2021 - 11/2009
5	Necrosis 06/2021 - 09/2010
5	Non-alcoholic Fatty Liver Disease 09/2019 - 10/2009
5	Infections 01/2017 - 01/2004
4	Gout 12/2021 - 01/2014
4	Body Weight (Weight, Body) 11/2021 - 11/2011
4	Asthma (Bronchial Asthma) 11/2021 - 01/2009
4	Hyperglycemia 06/2021 - 05/2008
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021 - 08/2016

Drug/Important Bio-Agent (IBA)

96	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2005
80	C-Reactive ProteinIBA 01/2022 - 07/2002
37	LipidsIBA 01/2021 - 07/2002
28	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2006
28	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2004
28	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2002
27	LDL CholesterolIBA 01/2021 - 12/2005
25	HDL CholesterolIBA 01/2022 - 01/2004
24	Fibrinogen (Factor I)FDA Link 01/2019 - 02/2003
23	AdiponectinIBA 01/2022 - 08/2005
22	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020 - 10/2004
18	CholesterolIBA 10/2022 - 10/2005
16	CytokinesIBA 10/2022 - 04/2002
16	TroponinIBA 01/2022 - 03/2010
15	Cystatin CIBA 01/2022 - 02/2005
15	Proteins (Proteins, Gene)FDA Link 06/2021 - 08/2003
15	oxidized low density lipoproteinIBA 01/2021 - 08/2005
14	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 12/2006
14	Insulin (Novolin)FDA Link 01/2022 - 02/2006
13	LeptinIBA 01/2022 - 02/2008
13	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2010
13	Troponin T (Troponin T1)IBA 01/2021 - 03/2010
12	darapladibIBA 12/2021 - 05/2014
12	Lipoproteins (Lipoprotein)IBA 02/2021 - 05/2003
11	AdipokinesIBA 01/2022 - 08/2004
11	InterleukinsIBA 06/2021 - 10/2005
11	Triglycerides (Triacylglycerol)IBA 10/2020 - 06/2013
10	CreatinineIBA 01/2022 - 12/2006
10	ChemokinesIBA 11/2018 - 12/2005
9	Uric Acid (Urate)IBA 12/2021 - 12/2005
9	ApolipoproteinsIBA 04/2019 - 10/2003
9	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2013 - 11/2002
7	omega-Chloroacetophenone (Mace)IBA 12/2021 - 07/2008
7	Natriuretic PeptidesIBA 11/2021 - 12/2006
7	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 11/2008
7	Vitamin D FDA LinkGeneric 01/2019 - 10/2011
7	Lipoprotein(a)IBA 08/2017 - 10/2003
7	Rosuvastatin Calcium (Crestor)FDA Link 05/2012 - 11/2008
7	Chemokine CCL5IBA 01/2011 - 12/2005
6	UromodulinIBA 01/2022 - 03/2019
6	AlbuminsIBA 12/2021 - 12/2010
6	Growth Differentiation Factor 15IBA 01/2021 - 01/2016
6	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021 - 01/2006
6	Troponin IIBA 01/2021 - 08/2016
6	Interleukin-18 (Interleukin 18)IBA 01/2018 - 10/2005
6	HDL LipoproteinsIBA 01/2018 - 09/2006
6	EnzymesIBA 05/2014 - 01/2007
6	Secretory Phospholipases A2IBA 01/2014 - 02/2009
5	canakinumab FDA Link 10/2022 - 01/2017
5	25-hydroxyvitamin DIBA 01/2022 - 10/2011
5	Peroxidase (Myeloperoxidase)IBA 01/2022 - 06/2012
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 05/2005
5	Peptides (Polypeptides)IBA 01/2022 - 08/2011
5	hydroxide ionIBA 01/2022 - 01/2013
5	PPAR alphaIBA 01/2019 - 04/2002
5	Phospholipases (Phospholipase)IBA 11/2013 - 02/2009
4	Monoclonal AntibodiesIBA 10/2022 - 01/2017
4	InflammasomesIBA 10/2022 - 01/2018
4	ProinsulinIBA 01/2022 - 02/2013
4	C-terminal proendothelin-1IBA 01/2022 - 01/2020
4	ReninIBA 01/2022 - 01/2016
4	AdrenomedullinIBA 01/2021 - 12/2012

Therapy/Procedure

45	Therapeutics 10/2022 - 07/2002
6	Secondary Prevention 01/2019 - 11/2002